A 23-year
A thyrotropin-producing pituitary adenoma is not a common disorder but to the best of our knowledge, there have been at least 22 cases reported previously in the literature and serum levels of TSH were determined by bioassay and/or radioimmunoassay (Jailer & Holub, 1960 ; Lamberg et al., 1969 ; Linquette et al., 1969 ; Hamilton et al., 1970 ; 1972 ; Faglia et al., 1972 ; Mornex et al., 1972 ; Hrubesch et al., 1972 ; O'Donnell et al., 1973 ; Demura et al., 1973 ; Baylis, 1976 ; Horn et al., 1976 ; Kourides et al., 1976 ; Tolis et al., 1978 ; Duello & Halmi, 1977 ; Smallridge et al., 1979 ; Waldhausl et al., 1979 ; Afrasiabi et al., 1979 ; Werner, 1979 ; Azukizawa et al., 1980) . We have observed a patient with a TSH producing adenoma ; he is the first of high stature and with clinical euthyroidism in spite of hypersecretion of thyroid hormones. Previously reported TSH secreting tumors associated with hyperthyroidism are also reviewed.
Case Report
A 23-year-old man was admitted to our hospital in April, 1980, for investigation of delayed puberty and high stature.
He had been in good health until the age of 10, when he was operated on for a right inguinal hernia.
As seen in Fig. 1 Serum free T4 was determined by radioimmunoassay utilizing the modified method described by Sterling and Hegedus (1962) and plasma hPRL by a radioimmunoassay using hPRL obtained from NIAMDD.
Plasma estrogen and progesterone were determined by the Eiken Immunochemical Laboratory (Tokyo, Japan) utilizing the method discribed by Tulchinsky and Abraham (1971) and Lindner et al., (1972) , respectively. Serum somatomedin A was determined by radio-receptorassay (Takano et al., 1976) . Antithyroglobulin and antimicrosomal antibodies were tested by hemagglutination, using reagent kits (Thyroid test for anti-thyroglobulin antiboby and Microsome test for antimicrosomal antibody, Fujizoki Pharmaceutical Co., Ltd.). For the determination of other clinical values, standard laboratory methods were used.
Hormone preparations and p-blocker used for treating the patient were obtained from various pharmaceutical companies, such as: TRH and LH-RH from Tanabe (Osaka, Japan), insulin (regular insulin) from Shimizu (Shimizu, Japan), hCG from Mochida (Tokyo, Japan), ACTH from N. V. Organon (Oss, Holland), triiodothyronine from Yamanouchi (Tokyo, Japan), glucagon from Novo (Copenhagen, Denmark), propranolol from Sumitomo (Osaka, Japan) and CB-154 from Sandoz (Basel, Switzerland). Intravenous administration was done as a bolus. Blood sampling was performed before and at the indicated times after various kinds of hormone administration.
The hormone content of the operated tumor tissue was determined after extraction with 0.2 N HC1. The supernatant was diluted with the respective buffers for RIA.
For electron microscopy, tumor tissue was fixed in 2.5% glutaraldehyde solution.
The immunohistochemical study was performed using the peroxidaselabeled antibody method described by Nakane & Pierce (1966) .
Anti-TSH rabbit antiserum was supplied by NIAMDD.
Discussion
This young man of high stature, with hypogonadism and bitemporal-upper-quadrantic visual defects was diagnosed clinically as having a TSH-producing pituitary adenoma based upon the following data; 1) The concentration of serum TSH was increased in spite of high levels of plasma thyroid hormone. 2) Elevated levels of TSH neither increased further after TRH administration nor dropped after exogenaus triiodothyronine administration.
3) Radiological study revealed the existence of a pituitary tumor. After the operation, this diagnosis was confirmed by 1) the immunohistochemical studies of the tumor tissue and 2) the normalization of plasma hormone levels.
Twenty two cases of pituitary TSH sec- retory tumor have been reported (Table 2 ). All cases showed clinical signs of hyperthyroidism and 11 cases (Linquete et al., 1969; Hamilton & Maloof, 1972; Faglia et al., 1972; Mornex et al., 1972; O'Donnell et al., 1973; Horn et al., 1976; Duello & Halmi, 1977; Smallridge et al., 1979; Waldhäusl et al., 1979 Our patient had a slightly enlarged struma; however, he did not exhibit any of the signs of hyperthyroidism such as tachycardia, tremor or increased perspiration. This may be due to the fact that he had only slightly elevated levels of thyroid hormone. However his lower than normal body weight and low level of serum cholesterol might be partially due to an increased metabolism.
A peripheral resistance to thyroid hormone, such as that seen in Refetoff syndrome, might be considered. However this syndrome showed the increase in TSH to TRH and/or paradoxical enhancement of the TSH response to TRH due to T3 administration in spite of elevated levels of thyroid hormone (Refetoff et al., 1980) . These results differ from those in our case. However, a partial resistance to thyroid hormone could not be ruled out. The possibility of primary hypothyroidism of long standing causing the pituitary tumor with euthyroidism can be ruled out from his past history, slightly elevated serum TSH level, and negative antibodies to thyroglobulin and microsome.
Our patient is the only one reported of high stature. In most of the cases reported in the literature, the tumor appeared after puberty.
Because of his growth curve (Fig. 1) , we speculate that the cause of the high stature in this case was as follows; GH secretion was normal until the age of 21; however, impaired secretion of gonadotropin caused a delayed fusion of the epiphyses. During this period, GH and thyroid hormone accelerated growth.
In last two years, growth ceased, indicating that the secretion of GH was impaired by enlargement of the tumor.
